SCHEMBL8097699

SCHEMBL8097699

CCC(CC)S(=O)(=O)NC(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.51
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
CA12 O43570 2/20 0.49
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA9 Q16790 2/20 0.49
CNR1 P21554 3/20 0.48
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
HTT P42858 2/20 0.47
MAPT P10636 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NLRP1 Q9C000 1/20 0.47
IDH1 O75874 1/20 0.46
LSS P48449 1/20 0.45
RECQL P46063 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
FAAH O00519 1/20 0.44
MGLL Q99685 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8089925 0.87 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8091346 0.83 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8083304 0.81 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL11221363 0.77 ALDH1A1 (0.61) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL9339230 0.77 FAAH (0.41) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL9339228 0.77 FAAH (0.41) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8091423 0.77 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8097633 0.76 ALDH1A1 (0.51) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL9485884 0.75 MEN1 (0.61) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL8083371 0.75 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed